These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 228442)

  • 21. Lowering effect of fenofibrate (procetofene) on lipoproteins in different types of hyperlipoproteinemias.
    Canzler H; Bojanovski D
    Artery; 1980; 8(2):171-8. PubMed ID: 7458684
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Serum lipoprotein lipids after gemfibrozil treatment.
    Schwandt P; Weisweiler P; Neureuther G
    Artery; 1979 Feb; 5(2):117-24. PubMed ID: 231950
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Effect of partial ileoshunting on hyperlipoproteinemia in patients with atherosclerosis].
    Sedletskiĭ IuI
    Vestn Khir Im I I Grek; 1985 Aug; 135(8):48-51. PubMed ID: 4060509
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Unusual xanthomas in a young patient with heterozygous familial hypercholesterolemia and type III hyperlipoproteinemia.
    Feussner G; Dobmeyer J; Nissen H; Hansen TS
    Am J Med Genet; 1996 Oct; 65(2):149-54. PubMed ID: 8911609
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of procetofen on serum lipids and apoproteins.
    Capurso A; Mogavero AM; Taverniti R; Resta F; Pace L; Bonomo L
    Int J Clin Pharmacol Ther Toxicol; 1984 Apr; 22(4):194-7. PubMed ID: 6715088
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Subclasses of low-density lipoprotein and very low-density lipoprotein in familial combined hyperlipidemia: relationship to multiple lipoprotein phenotype.
    Georgieva AM; van Greevenbroek MM; Krauss RM; Brouwers MC; Vermeulen VM; Robertus-Teunissen MG; van der Kallen CJ; de Bruin TW
    Arterioscler Thromb Vasc Biol; 2004 Apr; 24(4):744-9. PubMed ID: 14751815
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Serum thromboxane B2 and prostaglandin F2 alpha in familial combined hyperlipoproteinemia and familial hypercholesterolemia].
    Sziegoleit W; Wichmann T; Block HU; Taube C; Mest HJ
    Wien Klin Wochenschr; 1991; 103(8):227-31. PubMed ID: 1858388
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Lipids in myocardial infarction (author's transl)].
    Riese Jordá HH; Sanchis-Bayarri Vaillant V
    Med Clin (Barc); 1981 Nov; 77(8):318-21. PubMed ID: 7334885
    [No Abstract]   [Full Text] [Related]  

  • 29. [Blood plasma prostaglandins and their role in disorders of lipid metabolism in ischemic heart disease caused by coronary arteriosclerosis].
    Bochkareva EV; Zykova VP; Lobova NM; Polesskiĭ VA; Gadzhanova SI
    Ter Arkh; 1980; 52(5):18-22. PubMed ID: 7404361
    [No Abstract]   [Full Text] [Related]  

  • 30. [Effect of beta-pyridylcarbinol on lipids and lipoprotein in primary type IIa hyperlipoproteinemia].
    Hutt V; Wechsler JG; Klör HU; Ditschuneit H
    Arzneimittelforschung; 1983; 33(12):1682-4. PubMed ID: 6686774
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Serum lipids and lipoprotein following acute myocardial infarction in women.
    Birchwood B
    Nutr Metab; 1972; 14(1):38-47. PubMed ID: 4338729
    [No Abstract]   [Full Text] [Related]  

  • 32. [Distribution of the serum lipid levels in a population of healthy adults of both sexes between the ages of 20 and 30: correlation between these values].
    Mejean L; Mur JM; Drouin P; Gay G; Debry G
    C R Seances Soc Biol Fil; 1974; 168(8-9):1086-93. PubMed ID: 4376726
    [No Abstract]   [Full Text] [Related]  

  • 33. Low-density lipoprotein (LDL) receptors and the regulation of serum LDL levels.
    Vermeer BJ
    Neth J Med; 1985; 28(2):52-8. PubMed ID: 3919323
    [No Abstract]   [Full Text] [Related]  

  • 34. [Differential diagnosis of hyperlipoproteinemia using simultaneous determination of the lipids of the beta-prebeta lipoprotein group and of the lipid (beta and pre-beta)-cholesterol ratio].
    Girard ML; Delattre J; Legrand A; Canal J
    Ann Biol Clin (Paris); 1973; 31(2):91-3. PubMed ID: 4356118
    [No Abstract]   [Full Text] [Related]  

  • 35. The effects of pantethine on lipid and lipoprotein abnormalities in survivors of cerebral infarction.
    Murai A; Miyahara T; Tanaka T; Sako Y; Nishimura N; Kameyama M
    Artery; 1985; 12(4):234-43. PubMed ID: 3935096
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Behavior of the lipid pattern in acute and chronic myocardial infarct].
    Cottini E; Andreozzi GM; Nigro P; Sorrentino F
    Boll Soc Ital Cardiol; 1975; 20(11):1467-76. PubMed ID: 1234445
    [No Abstract]   [Full Text] [Related]  

  • 37. [Comparison of the hypolipemic effects of bezafibrate and fenofibrate in patients with hyperlipoproteinemia type II and IV].
    Sznajderman M
    Przegl Lek; 1984; 41(7):493-9. PubMed ID: 6390536
    [No Abstract]   [Full Text] [Related]  

  • 38. Is the serum total cholesterol an anachronism?
    Kannel WB; Castelli WP
    Lancet; 1979 Nov; 2(8149):950-1. PubMed ID: 91037
    [No Abstract]   [Full Text] [Related]  

  • 39. Effect of infusion of normal plasma on lipoproteins in type III hyperlipoproteinemia.
    Stuyt PM; Demacker PN; van 't Laar A
    Horm Metab Res; 1981 Dec; 13(12):715-6. PubMed ID: 7319472
    [No Abstract]   [Full Text] [Related]  

  • 40. [Stroke - the role of hyperlipoproteinemia. II. Lipid metabolism in stroke patients].
    Hulanicka K; Piechocki DW; Guzowski K
    Neurol Neurochir Pol; 1981; 15(4):459-67. PubMed ID: 7329511
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.